In-vitro cardiovascular protective activity of a new achillinoside from Achillea alpina

AUTOR(ES)

Zhou, Fei

FONTE

Rev. bras. farmacogn.

DATA DE PUBLICAÇÃO

17/10/2019

RESUMO

Abstract Achillinoside was isolated from methanol extract of Achillea alpina L., Asteraceae. The structure of the compound was characterized based on various spectrum data, including IR, HR-ESI-MS, 1D and 2D NMR. The cardiovascular protective effect of achillinoside was tested on H2O2-induced H9c2 cells. In our research, achillinoside could increase the cell viability dose-dependently in H2O2-induced H9c2 cells. In addition, the levels of caspase-3/9 cells were significantly decreased in H2O2 and achillinoside incubated H9c2 cells.

Documentos Relacionados

• In-vitro antigonococcal activity of rosoxacin (WIN 35213).
• Comparative in-vitro activity of selected new beta-lactam antimicrobials against Neisseria gonorrhoeae.
• In-vitro antimicrobial susceptibility of Neisseria gonorrhoeae in New Zealand.
• In-vitro activity of antimicrobial agents against Neisseria gonorrhoeae in Brussels.
• In-vitro activity of 21 antimicrobial agents against Neisseria gonorrhoeae in Brussels.